Bone trauma and related benign disease: assessment by bone scanning.
The radionuclide investigation of skeletal trauma in the past was confined generally to scintimetry and an occasional bone scan. The development of improved radiopharmaceuticals, including 99mTc-labeled compounds with their enhanced sensitivity, and the refinement of imaging devices offering superior resolution and speed have allowed a more detailed assessment of conditions resulting from trauma. Practical approaches to the diagnosis of subtle bone injury resulting in stress fracture, the differentiation between delayed healing and nonunion, and early recognition of avascular necrosis and osteomyelitis are now available. The changing pattern of radionuclide uptake in bone following damage by radiation and other abnormalities as a consequence of trauma also can be easily studied.
D000293:Adolescent; D000328:Adult; D001265:Athletic Injuries / Q000175:diagnosis; D002132:Calcium Radioisotopes; D002648:Child; D011756:Diphosphates; D005260:Female; D005271:Femur Head Necrosis / Q000175:diagnosis*; D005461:Fluorine; D050723:Fractures, Bone / Q000175:diagnosis*; D005598:Fractures, Spontaneous / Q000175:diagnosis; D005599:Fractures, Ununited / Q000175:diagnosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009221:Myositis Ossificans / Q000175:diagnosis; D010019:Osteomyelitis / Q000175:diagnosis*; D011832:Radiation Injuries / Q000175:diagnosis; D011877:Radionuclide Imaging; D011878:Radiotherapy / Q000009:adverse effects; D013326:Strontium Radioisotopes; D013667:Technetium
D002132:Calcium Radioisotopes; D011756:Diphosphates; D013326:Strontium Radioisotopes; D005461:Fluorine; D013667:Technetium